Year-over-year, this metric declined by 4.7%, from -$214.00M to -$224.00M. Over 3 years (FY 2022 to FY 2025), Other Income (Expense) shows a downward trend with a 12.7% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$158.00M | -$127.00M | -$188.00M | -$206.00M | -$56.00M | -$21.00M | -$151.00M | -$153.00M | -$196.00M | -$302.00M | -$210.00M | -$260.00M | -$167.00M | -$234.00M | -$214.00M | -$240.00M | -$220.00M | $0.00 | -$224.00M |
| QoQ Change | — | +19.6% | -48.0% | -9.6% | +72.8% | +62.5% | -619.0% | -1.3% | -28.1% | -54.1% | +30.5% | -23.8% | +35.8% | -40.1% | +8.5% | -12.1% | +8.3% | +100.0% | — |
| YoY Change | — | — | — | -30.4% | +55.9% | — | +19.7% | +25.7% | -250.0% | <-999% | -39.1% | -69.9% | +14.8% | +22.5% | -1.9% | +7.7% | -31.7% | +100.0% | -4.7% |